Aadi Bioscience, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$5.92 | $223.86 M | -2.51 | 58 | $0 |
ADAG
Adagene Inc. |
$1.96 | $131.46 M | -6.77 | 174 | $18.11 M |
ANAB
AnaptysBio, Inc. |
$13.03 | $640.07 M | -3.82 | 117 | $17.16 M |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.70 | $56.28 M | -5.86 | 2 | $0 |
ANTX
AN2 Therapeutics, Inc. |
$1.45 | $60.55 M | -0.81 | 41 | $0 |
ARVN
Arvinas, Inc. |
$19.01 | $1.83 B | -4.41 | 445 | $78.50 M |
AVTE
Aerovate Therapeutics, Inc. |
$2.68 | $597.48 M | -6.84 | 51 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$51.87 | $3.53 B | -11.86 | 290 | $4.01 M |
DSGN
Design Therapeutics, Inc. |
$6.25 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$2.55 | $647.94 M | -2.83 | 126 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$7.06 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
KURA
Kura Oncology, Inc. |
$8.67 | $1.66 B | -10.03 | 142 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$12.84 | $652.38 M | -6.03 | 28 | $0 |
RARE
Ultragenyx Pharmaceutical Inc. |
$43.42 | $3.44 B | -5.21 | 1276 | $434.25 M |
RVMD
Revolution Medicines, Inc. |
$44.21 | $6.66 B | -10.51 | 490 | $11.58 M |
RZLT
Rezolute, Inc. |
$4.96 | $229.57 M | -5.02 | 59 | $0 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |